COMPANY PROFILE

Portal Biotech

Explore full profile

Bench-top nanopore solutions for single-molecule protein characterisation

London, United KingdomFounded 2021Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Portal Biotech

Portal Biotech Limited specializes in advanced proteomic and metabolomic analysis, offering real-time data solutions that provide fast and comprehensive answers to biological questions. The company's technology allows for complete coverage of proteins at the single molecule level, ensuring no loss of information during analysis. Portal Biotech serves both small and high-volume laboratories with accessible and affordable instruments and cartridges, integrating seamlessly into existing workflows. The business operates in the life sciences market, focusing on proteoform quantitation and profiling, which is crucial for developing better diagnostics and drug designs. Revenue is generated through the sale of instruments and consumables, catering to the needs of research institutions and biotech companies.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2021
Headquarters: London, United Kingdom
Employees: 65
Open positions: 4
Dealroom signal: 92.1/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Techbio, Techbio Drug Discovery, NIF defense security and resilience, NIF biotech, NIF Crisis preparedness, proteomics, DT and LS
Technology: Hardware, Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Open roles

5 open roles

Product Development ScientistEngineering · London, UK · 4d ago Biologics Production ScientistEngineering · London, UK · 4d ago Front-end Software Engineer (Contractor)Engineering · London, UK · 1w ago Senior Software Test EngineerEngineering · London, UK · 1w ago Senior Full-Stack Software EngineerEngineering · London, UK · 1w ago

From job postings in the last four months.More startups hiring →

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jun 2025	$35M	$140M	8VC · Pillar VC · Amino Collective · Outsized Ventures	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Portal Biotech website traffic

Latest recorded traffic for Portal Biotech is 6K monthly website visits, down 28.6% over the last three months. Portal Biotech's team grew 364.3% over the past year.

Latest monthly visits6K 3-month web change-28.6% 1-year team growth+364.3%

Monthly website visitsJan 2025–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Manufacturing Support TechnicianLondon, England, United Kingdom · Other · Jul 13, 2026 Applications Scientist (1-year fixed-term contract)London, England, United Kingdom · Data Science & Engineering · Jun 24, 2026

2 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CACardiaTecApplying artificial intelligence on large-scale human multiomic data to develop the next generation of cardiovascular disease targets	Cambridge, United Kingdom	Operational	17	$8.7M	$26M
PCPeptone - The Protein Intelligence CompanyA translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins	London, United Kingdom	Operational
MHMultiomic HealthAI-enabled precision medicine for metabolic syndrome-related conditions	London, United Kingdom	Operational
ILIgnota LabsUsing cutting-edge AI algorithms to predict toxic endpoints, earlier in the drug discovery process	London, United Kingdom	Operational
CECellVoyantAn AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases	Bristol, United Kingdom	Operational
MLMicrographia Bio LtdAI-powered spatial proteomics platform for drug discovery.	London, United Kingdom	Operational
BIBioCorteXCures neurodegenerative diseases by hacking the microbiome and delivering enhanced therapeutics as soon as possible	London, United Kingdom	Operational
EXExogeneBiotechnology company accelerating target and TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening	Oxford, United Kingdom	Operational